The therapeutic potential of natural metabolites in targeting endocrine-independent HER-2-negative breast cancer
M Püsküllüoğlu, I Michalak - Frontiers in Pharmacology, 2024 - frontiersin.org
Breast cancer (BC) is a heterogenous disease, with prognosis and treatment options
depending on Estrogen, Progesterone receptor, and Human Epidermal Growth Factor …
depending on Estrogen, Progesterone receptor, and Human Epidermal Growth Factor …